Teladoc Health, Inc. Shs Unsponsored Brazilian Depositary Receipt Repr 0.033333333 Sh (T2DH34) Stock Price & Analysis

T2DH34 Stock Chart & Stats

R$46.46-R$1.10(29.99%)

At close: Oct 30

Day’s Range: BRL 46.46 - BRL 48.04
52-Week Range: BRL 21.60 - BRL 52.20
Previous Close: BRL 35.74
Volume: N/A
Average Volume (3M): 223
Market Cap: BRL 8.44B
Enterprise Value: BRL 165.59B
Total Cash (Recent Filing): N/A
Total Debt (Recent Filing): N/A
Price to Earnings (P/E): ―
Beta: -0.93
Next Earnings: Feb 23, 2027 (Est.)
EPS Estimate: N/A
Next Dividend Ex-Date: N/A
Dividend Yield: N/A

Teladoc Health, Inc. Shs Unsponsored Brazilian Depositary Receipt Repr 0.033333333 Sh News

Teladoc price target raised to $10 from $8 at JPMorgan

JPMorgan raised the firm’s price target on Teladoc (TDOC) to $10 from $8 and keeps a Neutral rating on the shares. Published first on TheFly – the ultimate source for

2d agoTDOC 4LL

Teladoc Maintained at Buy as Operational Momentum and Insurance Shift Support Risk/Reward; $10 Price Target Reiterated

Analyst Richard Close from Canaccord Genuity maintained a Buy rating on Teladoc and keeping the price target at $10.00. Richard Close has given his Buy rating due to a combination

3d agoTDOC 4LL

Private Markets: Claude developer Anthropic files to go public

Anthropic has publicly filed for a Nasdaq IPO, with the Claude developer widely expected to debut in mid-November at a valuation that could top $2 trillion. Meanwhile, cloud and AI

3d agoAI DE

Midday Fly By: Alphabet plunges, Microsoft dips after earnings

The major averages were broadly lower near noon as investors digest results from Alphabet and Microsoft. Hyperscaler peer Amazon joins the parade with its own earnings report due after the

3d agoON ADT

Teladoc price target raised to $6.50 from $5.50 at Stifel

Stifel raised the firm’s price target on Teladoc (TDOC) to $6.50 from $5.50 and keeps a Hold rating on the shares. Published first on TheFly – the ultimate source for

3d agoTDOC 4LL

Closing Bell Movers: Alphabet down 9% after earnings miss

Major indices finished the day marginally higher after the Federal Reserve left the Fed Funds rate unchanged as expected in a 10-2 vote and Fed Chair Warsh struck a mixed

3d agoF CMG

Teladoc reports Q3 EPS (15c), consensus (21c)

Reports Q3 revenue $605.1M, consensus $590.09M. “We delivered third quarter results near the upper end of our guidance range for consolidated revenue and above our range for consolidated adjusted EBITDA,

4d agoTDOC 4LL

Teladoc sees FY26 EPS (95c)-(75c), consensus (89c)

Sees FY26 revenue $2.395B-$2.441B, consensus $2.42B. Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>> See today’s best-performing stocks on TipRanks >> Read

4d agoTDOC 4LL

Teladoc sees Q4 EPS (23c)-(3c), consensus (11c)

Sees Q4 revenue $569M-$615M, consensus $599.41M. Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>> See the top stocks recommended by analysts >>

4d agoTDOC 4LL

Teladoc options imply 9.6% move in share price post-earnings

Pre-earnings options volume in Teladoc (TDOC) is 2.2x normal with calls leading puts 2:1. Implied volatility suggests the market is anticipating a move near 9.6%, or 64c, after results are

4d agoTDOC 4LL

Teladoc announces resignation of CLO Vandervoort, Dorfman to succeed

Teladoc (TDOC) Health announced a leadership transition in its legal function. After 11 years with the company, Adam Vandervoort, Chief Legal Officer, CLO, and Secretary, has informed the company of

1M agoTDOC 4LL

Teladoc Buy Rating Reaffirmed as New CFO Appointment Stabilizes Leadership; $10 Price Target Maintained

In a report released yesterday, Richard Close from Canaccord Genuity maintained a Buy rating on Teladoc, with a price target of $10.00. Richard Close has given his Buy rating due

2M agoTDOC 4LL

Analyst Maintains Buy Rating on Teladoc with Unchanged $10.50 Price Target Amid Strategic Transition and New CFO Appointment

Bank of America Securities analyst Allen Lutz reiterated a Buy rating on Teladoc yesterday and set a price target of $10.50. Allen Lutz has given his Buy rating due to

2M agoTDOC 4LL

Teladoc: Mixed Business Performance and BetterHelp Growth Uncertainty Keep Ryan MacDonald at Hold

Needham analyst Ryan MacDonald has reiterated their neutral stance on TDOC stock, giving a Hold rating today. Ryan MacDonald has given his Hold rating due to a combination of factors,

3M agoTDOC 4LL

T2DH34 FAQ

What was Teladoc Health, Inc. Shs Unsponsored Brazilian Depositary Receipt Repr 0.033333333 Sh’s price range in the past 12 months?

Teladoc Health, Inc. Shs Unsponsored Brazilian Depositary Receipt Repr 0.033333333 Sh lowest stock price was R$21.60 and its highest was R$52.20 in the past 12 months.

What is Teladoc Health, Inc. Shs Unsponsored Brazilian Depositary Receipt Repr 0.033333333 Sh’s market cap?

Teladoc Health, Inc. Shs Unsponsored Brazilian Depositary Receipt Repr 0.033333333 Sh’s market cap is R$8.44B.

When is Teladoc Health, Inc. Shs Unsponsored Brazilian Depositary Receipt Repr 0.033333333 Sh’s upcoming earnings report date?

The company’s upcoming earnings report date is not yet available.

How were Teladoc Health, Inc. Shs Unsponsored Brazilian Depositary Receipt Repr 0.033333333 Sh’s earnings last quarter?

Teladoc Health, Inc. Shs Unsponsored Brazilian Depositary Receipt Repr 0.033333333 Sh released its earnings results on Oct 28, 2026. The company reported R$0 earnings per share for the quarter.

Is Teladoc Health, Inc. Shs Unsponsored Brazilian Depositary Receipt Repr 0.033333333 Sh overvalued?

Not enough analysts have published a price target to calculate whether the price is overvalued.

Does Teladoc Health, Inc. Shs Unsponsored Brazilian Depositary Receipt Repr 0.033333333 Sh pay dividends?

Teladoc Health, Inc. Shs Unsponsored Brazilian Depositary Receipt Repr 0.033333333 Sh does not currently pay dividends.

What is Teladoc Health, Inc. Shs Unsponsored Brazilian Depositary Receipt Repr 0.033333333 Sh’s EPS estimate?

Teladoc Health, Inc. Shs Unsponsored Brazilian Depositary Receipt Repr 0.033333333 Sh’s EPS estimate for its next earnings report is not yet available.

How many shares outstanding does Teladoc Health, Inc. Shs Unsponsored Brazilian Depositary Receipt Repr 0.033333333 Sh have?

Teladoc Health, Inc. Shs Unsponsored Brazilian Depositary Receipt Repr 0.033333333 Sh has 5,451,066,000 shares outstanding.

What happened to Teladoc Health, Inc. Shs Unsponsored Brazilian Depositary Receipt Repr 0.033333333 Sh’s price movement after its last earnings report?

Teladoc Health, Inc. Shs Unsponsored Brazilian Depositary Receipt Repr 0.033333333 Sh reported an EPS of R$0 in its last earnings report. Following the earnings report the stock price went up 33.072%.

Which hedge fund is a major shareholder of Teladoc Health, Inc. Shs Unsponsored Brazilian Depositary Receipt Repr 0.033333333 Sh?

Currently, no hedge funds are holding shares in BR:T2DH34

What is the TipRanks Smart Score and how is it calculated?

Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

Teladoc Health, Inc. Shs Unsponsored Brazilian Depositary Receipt Repr 0.033333333 Sh (T2DH34) Earnings & Revenues

Historic Earnings Reports

Technical Analysis

Overall Consensus

Indicator	Bullish	Neutral	Bearish
Overall Consensus	14	4	4
Technical Analysis	2	4	4
Moving Averages	12	0	0

Technical Analysis >

Similar Stocks

Stocks similar to BR:T2DH34
Company	Price & Change	Follow
BR:A2FY34Afya Limited Unsponsored BDR A
BR:CLOV34Clover Health Investments Corp. Shs A Unsponsored Brazilian Depositary Receipt Repr 1 Sh A
BR:HAPV3Hapvida Participacoes e Investimentos SA
BR:T2ND34Tandem Diabetes Care, Inc. Shs Unsponsored Brazilian Depositary Receipt Repr 0.066666 Sh
BR:FLRY3Fleury SA

Compare BR:T2DH34 Stocks >

Popular Stocks

Popular Stocks
Company	Price & Change	Follow
NVDANvidia
AAPLApple
MSFTMicrosoft

T2DH34 Stock Chart & Stats

Teladoc Health, Inc. Shs Unsponsored Brazilian Depositary Receipt Repr 0.033333333 Sh News

Teladoc price target raised to $10 from $8 at JPMorgan

Teladoc Maintained at Buy as Operational Momentum and Insurance Shift Support Risk/Reward; $10 Price Target Reiterated

Private Markets: Claude developer Anthropic files to go public

Midday Fly By: Alphabet plunges, Microsoft dips after earnings

Teladoc price target raised to $6.50 from $5.50 at Stifel

Closing Bell Movers: Alphabet down 9% after earnings miss

Teladoc reports Q3 EPS (15c), consensus (21c)

Teladoc sees FY26 EPS (95c)-(75c), consensus (89c)

Teladoc sees Q4 EPS (23c)-(3c), consensus (11c)

Teladoc options imply 9.6% move in share price post-earnings

Teladoc announces resignation of CLO Vandervoort, Dorfman to succeed

Teladoc Buy Rating Reaffirmed as New CFO Appointment Stabilizes Leadership; $10 Price Target Maintained

Analyst Maintains Buy Rating on Teladoc with Unchanged $10.50 Price Target Amid Strategic Transition and New CFO Appointment

Teladoc: Mixed Business Performance and BetterHelp Growth Uncertainty Keep Ryan MacDonald at Hold

T2DH34 FAQ

Teladoc Health, Inc. Shs Unsponsored Brazilian Depositary Receipt Repr 0.033333333 Sh (T2DH34) Earnings & Revenues

Technical Analysis

Overall Consensus

Similar Stocks

Popular Stocks

Become an Expert with TipRanks Premium